Juventas Cell Therapy Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Juventas Cell Therapy Ltd.
RECRUITINGPhase 2NCT04586478
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
The study is a Phase II, single-arm, open-label, single-dose clinical trial, and its primary objective is to evaluate the efficacy and safety of CNCT19 Cell Injection in the...
Sponsor: Juventas Cell Therapy Ltd.Enrolling: 6017 locations
Non-Hodgkin's Lymphoma
RECRUITINGPhase 1NCT06826430
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune...
This is a single-arm, open-label，phase I clinical study to evaluate the safety and tolerability of Inaticabtagene Autoleucel Injection in treatment of refractory systemic lupus...
Sponsor: Juventas Cell Therapy Ltd.Enrolling: 121 location
Autoimmune Thrombocytopenia